Guizhou Sanli Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.021x

Guizhou Sanli Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Guizhou Sanli Pharmaceutical Co Ltd (603439) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥33.19 Million ≈ $4.86 Million USD) by net assets (CN¥1.55 Billion ≈ $226.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Guizhou Sanli Pharmaceutical Co Ltd (2013–2024)

Cash flow conversion efficiency of Guizhou Sanli Pharmaceutical Co Ltd from 2013 to 2024. This chart illustrates how Guizhou Sanli Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Guizhou Sanli Pharmaceutical Co Ltd (603439) stock price for real-time trading data and today's change.

Guizhou Sanli Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Guizhou Sanli Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Guizhou Sanli Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guizhou Sanli Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 603439 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Ning Xia Yin Xing Energy Co Ltd SHE:000862	0.040x
Svolder AB (publ) ST:SVOL-B	0.002x
Fineotex Chemical Limited NSE:FCL	0.021x
Haoxiangni Jujube Co Ltd SHE:002582	0.029x
We Buy Cars Hlds Ltd JSE:WBC	N/A
Wave Life Sciences Ltd NASDAQ:WVE	-0.116x
Hefei Fengle Seed Co Ltd SHE:000713	0.076x
Sigma Lithium Resources Corp NASDAQ:SGML	0.020x

Annual Cash Flow Conversion Efficiency for Guizhou Sanli Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Guizhou Sanli Pharmaceutical Co Ltd from 2013 to 2024. Review Guizhou Sanli Pharmaceutical Co Ltd (603439) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.59 Billion ≈ $233.34 Million	CN¥107.07 Million ≈ $15.67 Million	0.067x	-58.52%
2023-12-31	CN¥1.71 Billion ≈ $250.13 Million	CN¥276.70 Million ≈ $40.49 Million	0.162x	-31.66%
2022-12-31	CN¥1.24 Billion ≈ $181.19 Million	CN¥293.29 Million ≈ $42.92 Million	0.237x	+57.68%
2021-12-31	CN¥1.03 Billion ≈ $151.02 Million	CN¥155.04 Million ≈ $22.69 Million	0.150x	+133.21%
2020-12-31	CN¥981.88 Million ≈ $143.68 Million	CN¥63.25 Million ≈ $9.26 Million	0.064x	-63.92%
2019-12-31	CN¥651.09 Million ≈ $95.27 Million	CN¥116.24 Million ≈ $17.01 Million	0.179x	+22.74%
2018-12-31	CN¥518.02 Million ≈ $75.80 Million	CN¥75.35 Million ≈ $11.03 Million	0.145x	+19.81%
2017-12-31	CN¥473.36 Million ≈ $69.27 Million	CN¥57.47 Million ≈ $8.41 Million	0.121x	+48.93%
2016-12-31	CN¥430.59 Million ≈ $63.01 Million	CN¥35.10 Million ≈ $5.14 Million	0.082x	-46.96%
2015-12-31	CN¥216.53 Million ≈ $31.68 Million	CN¥33.28 Million ≈ $4.87 Million	0.154x	+2870.82%
2014-12-31	CN¥108.92 Million ≈ $15.94 Million	CN¥563.46K ≈ $82.45K	0.005x	-98.81%
2013-12-31	CN¥69.09 Million ≈ $10.11 Million	CN¥30.09 Million ≈ $4.40 Million	0.435x	--

About Guizhou Sanli Pharmaceutical Co Ltd

SHG:603439 China Drug Manufacturers - Specialty & Generic

Market Cap

$648.66 Million

CN¥4.43 Billion CNY

Market Cap Rank

#10605 Global

#2847 in China

Share Price

CN¥10.84

Change (1 day)

-4.16%

52-Week Range

CN¥9.68 - CN¥17.00

All Time High

CN¥41.67